{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:15:21Z","timestamp":1774361721129,"version":"3.50.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013227","name":"Health Promotion Administration, Ministry of Health and Welfare","doi-asserted-by":"crossref","award":["MOHW105-NHI-S-114-000004"],"award-info":[{"award-number":["MOHW105-NHI-S-114-000004"]}],"id":[{"id":"10.13039\/100013227","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Determining the clinically optimal dose in methadone maintenance therapy (MMT) is a time-consuming procedure, which considers clinical signs and symptoms.<\/jats:p>\n            <jats:p>To perform a quantitative trait locus association for identifying genetic variants for MMT dosage that underlie heroin addiction and methadone metabolism and then integrate several genotypic and phenotypic factors are potential predictors for clinically optimal MMT dose for personalized prescription.<\/jats:p>\n            <jats:p>In total, 316 heroin-dependent patients undergoing MMT were recruited at the Addiction Center of the China Medical University Hospital. A multinomial logistic regression model was used to assess associations between genetic polymorphisms and MMT dosing. The data were randomly separated into training and testing sets. In order to enhance the prediction accuracy and the reliability of the prediction model, we used areas under the receiver operating characteristic curves to evaluate optimal MMT dose in both training and testing sets.<\/jats:p>\n            <jats:p>Four single nucleotide polymorphisms, namely rs806368 in <jats:italic toggle=\"yes\">CNR1<\/jats:italic>, s1386493 in <jats:italic toggle=\"yes\">TPH2<\/jats:italic>, s16974799 in <jats:italic toggle=\"yes\">CYP2B6<\/jats:italic>, and rs2229205 in <jats:italic toggle=\"yes\">OPRL1<\/jats:italic>, were significantly associated with the maximum MMT dose (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). The genetic risk score (GRS) was associated with maximum MMT dose, and after adjustments for age, sex, and body mass index, the GRS remained independently associated with the maximum MMT dose. The area under the receiver operating characteristic curve of the combined GRS and craving score was 0.77 for maximum MMT dose, with 75% sensitivity and 60% specificity.<\/jats:p>\n            <jats:p>Integrating the GRS and craving scores may be useful in the evaluation of individual MMT dose requirements at treatment initiation. Optimal dose prediction allows clinicians to tailor MMT to each patient's needs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000020429","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T19:24:55Z","timestamp":1590693895000},"page":"e20429","source":"Crossref","is-referenced-by-count":4,"title":["Precision therapeutic opioid dosing implications from genetic biomarkers and craving score"],"prefix":"10.1097","volume":"99","author":[{"given":"Hsin-Wen","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Public Health, China Medical University, Taichung"},{"name":"Center for General Education, Hsuan Chuang University, Hsinchu City"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chao","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Public Health, China Medical University, Taichung"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieh-Liang","family":"Huang","sequence":"additional","affiliation":[{"name":"Brain Disease Research Center"},{"name":"Center for Drug Abuse and Addiction, China Medical University Hospital, Taichung, Taiwan"},{"name":"College of Medicine, China Medical University, Taichung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8262-0873","authenticated-orcid":false,"given":"Ruey-Yun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Public Health, China Medical University, Taichung"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"R1-20240308","first-page":"1047","article-title":"Prevalence of impairments, disabilities, handicaps and quality of life in the general population: a review of recent literature","volume":"79","author":"Barbotte","year":"2001","journal-title":"Bull World Health Organ"},{"key":"R2-20240308","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2217\/pgs-2018-0017","article-title":"The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review","volume":"19","author":"Oueslati","year":"2018","journal-title":"Pharmacogenomics"},{"key":"R3-20240308","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1186\/1471-2458-12-1066","article-title":"Prevalences and associated risk factors of HCV\/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan","volume":"12","author":"Yen","year":"2012","journal-title":"BMC Public Health"},{"key":"R4-20240308","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J069v21n03_01","article-title":"Optimizing long-term response to methadone maintenance treatment: a 152-week follow-up using higher-dose methadone","volume":"21","author":"Maxwell","year":"2002","journal-title":"J Addict Dis"},{"key":"R5-20240308","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.57.1.1","article-title":"Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments","volume":"57","author":"Kreek","year":"2005","journal-title":"Pharmacol Rev"},{"key":"R6-20240308","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/10408363.2011.620601","article-title":"Methadone: a review of drug-drug and pathophysiological interactions","volume":"48","author":"Kapur","year":"2011","journal-title":"Crit Rev Clin Lab Sci"},{"key":"R7-20240308","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2217\/pgs.14.19","article-title":"Assessment of CYP450 genetic variability effect on methadone dose and tolerance","volume":"15","author":"Tsai","year":"2014","journal-title":"Pharmacogenomics"},{"key":"R8-20240308","doi-asserted-by":"crossref","first-page":"e19527","DOI":"10.1371\/journal.pone.0019527","article-title":"Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response","volume":"6","author":"Fonseca","year":"2011","journal-title":"PLoS One"},{"key":"R9-20240308","doi-asserted-by":"crossref","first-page":"e75359","DOI":"10.1371\/journal.pone.0075359","article-title":"Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study","volume":"8","author":"Beer","year":"2013","journal-title":"PLoS One"},{"key":"R10-20240308","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1111\/jcmm.13266","article-title":"Reduced dosing and liability in methadone maintenance treatment by targeting oestrogen signal for morphine addiction","volume":"21","author":"Chiang","year":"2017","journal-title":"J Cell Mol Med"},{"key":"R11-20240308","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2217\/pgs-2017-0040","article-title":"Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives","volume":"18","author":"Marie-Claire","year":"2017","journal-title":"Pharmacogenomics"},{"key":"R12-20240308","doi-asserted-by":"crossref","first-page":"e86114","DOI":"10.1371\/journal.pone.0086114","article-title":"Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: a systematic review and meta-analysis","volume":"9","author":"Dennis","year":"2014","journal-title":"PLoS One"},{"key":"R13-20240308","doi-asserted-by":"crossref","first-page":"229","DOI":"10.31887\/DCNS.2017.19.3\/wberrettini","article-title":"A brief review of the genetics and pharmacogenetics of opioid use disorders","volume":"19","author":"Berrettini","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"key":"R14-20240308","doi-asserted-by":"crossref","first-page":"e1005910","DOI":"10.1371\/journal.pgen.1005910","article-title":"Genome-wide pharmacogenomic study on methadone maintenance treatment identifies SNP rs17180299 and multiple haplotypes on CYP2B6, SPON1, and GSG1L associated with plasma concentrations of methadone R- and S-enantiomers in heroin-dependent patients","volume":"12","author":"Yang","year":"2016","journal-title":"PLoS Genet"},{"key":"R15-20240308","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/mp.2016.257","article-title":"Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1","volume":"22","author":"Smith","year":"2017","journal-title":"Mol Psychiatry"},{"key":"R16-20240308","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1742-7843.2010.00628.x","article-title":"Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation","volume":"108","author":"Chang","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R17-20240308","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.106.117580","article-title":"Enantiomeric metabolic interactions and stereoselective human methadone metabolism","volume":"321","author":"Totah","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"R18-20240308","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0b013e3181642938","article-title":"Role of CYP2B6 in stereoselective human methadone metabolism","volume":"108","author":"Totah","year":"2008","journal-title":"Anesthesiology"},{"key":"R19-20240308","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","article-title":"Monoamine neurocircuitry in depression and strategies for new treatments","volume":"45","author":"Hamon","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R20-20240308","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pharmtox-010611-134625","article-title":"Addiction circuitry in the human brain","volume":"52","author":"Volkow","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R21-20240308","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/archpsyc.65.7.816","article-title":"Cannabinoid receptor 1 gene association with nicotine dependence","volume":"65","author":"Chen","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"R22-20240308","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/ajmg.b.30881","article-title":"Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence","volume":"150B","author":"Agrawal","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R23-20240308","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1530-0277.2011.01623.x","article-title":"Cannabinoid receptor 1 gene is associated with alcohol dependence","volume":"36","author":"Marcos","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"key":"R24-20240308","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1369-1600.2011.00346.x","article-title":"Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis","volume":"18","author":"Clarke","year":"2013","journal-title":"Addict Biol"},{"key":"R25-20240308","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/sj.mp.4001560","article-title":"Human cannabinoid receptor 1: 5\u2019 exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse","volume":"9","author":"Zhang","year":"2004","journal-title":"Mol Psychiatry"},{"key":"R26-20240308","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/ajad.12273","article-title":"A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients","volume":"24","author":"Icick","year":"2015","journal-title":"Am J Addict"},{"key":"R27-20240308","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000279322","article-title":"Tryptophan hydroxylase as novel target for the treatment of depressive disorders","volume":"85","author":"Matthes","year":"2010","journal-title":"Pharmacology"},{"key":"R28-20240308","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1601-183X.2012.00839.x","article-title":"Modifying the role of serotonergic 5-HTTLPR and TPH2 variants on disulfiram treatment of cocaine addiction: a preliminary study","volume":"11","author":"Nielsen","year":"2012","journal-title":"Genes Brain Behav"},{"key":"R29-20240308","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2210-6-6","article-title":"Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs","volume":"6","author":"Han","year":"2006","journal-title":"BMC Pharmacol"},{"key":"R30-20240308","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10519-007-9187-7","article-title":"TPH2 and TPH1: association of variants and interactions with heroin addiction","volume":"38","author":"Nielsen","year":"2008","journal-title":"Behav Genet"},{"key":"R31-20240308","doi-asserted-by":"crossref","first-page":"e0201408","DOI":"10.1371\/journal.pone.0201408","article-title":"Impacts of GRIN3A, GRM6 and TPH2 genetic polymorphisms on quality of life in methadone maintenance therapy population","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"key":"R32-20240308","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/mp.2012.164","article-title":"Genome-wide association study identifies a potent locus associated with human opioid sensitivity","volume":"19","author":"Nishizawa","year":"2014","journal-title":"Mol Psychiatry"},{"key":"R33-20240308","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2217\/pgs.15.151","article-title":"Genome-wide association study identifies candidate loci associated with postoperative fentanyl requirements after laparoscopic-assisted colectomy","volume":"17","author":"Mieda","year":"2016","journal-title":"Pharmacogenomics"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T20:19:30Z","timestamp":1709929170000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":33,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000020429","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]}}}